Skip to content

Study on Vitamin C , Thiamine and Hydrocortisone in Septic shock patients

A comparative study on combination therapy of Hydrocortisone, Vitamin C and Thiamine to Hydrocortisone alone in Septic shock patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070812
Enrollment
148
Registered
2024-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R652- Severe sepsis

Interventions

Intervention1: Vitamin C , Thiamine and Hydrocortisone: Supplementation with Vitamin C (1.5gm), Thiamine(100 mg) and Hydrocortisone (50mg) every 6 hours for 4 days + Specific treatment -Standard of c

Sponsors

Dasari Sai Divya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) Patients in septic shock with vasopressor requirement : a continuous infusion of epinephrine, vasopressin, nor epinephrine, dopamine or other vasopressor agent at any dose required to maintain a mean arterial pressure of at least 65 mm hg despite intravenous crystalloid resuscitation of at least 30 ml/kg (2) Suspected or confirmed infection as evidenced by the ordering of blood and urine cultures and the administration of at least one antimicrobial agent (3) Patients who are candidates for ICU admission

Exclusion criteria

Exclusion criteria: (1) Shock due to other causes (2) Limitations of care (defined as refusal of cardiovascular and respiratory support modes) including "do not intubate" status (3) known allergy or known contraindication to Vitamin C , Thiamine , or corticosteroids (4) Chronic illness / disease that, in opinion of the site investigator , has an expected life span of less than 30 days unrelated to current sepsis diagnosis ( example: stage IV malignancy and neurodegenerative disease ) (5) Pregnancy or known active breast feeding

Design outcomes

Primary

MeasureTime frame
(1) Vasopressor and ventilator free days (VVFD) (2) SOFA score (3) New onset AKI resolutionTimepoint: (1) Vasopressor and ventilator free days (VVFD) at baseline, at 3 days, at 1 week, at 2 weeks, at 4 weeks. (2) SOFA score - initial assessment and at baseline, at 3 days, at 1 week, at 2 weeks, at 4 weeks. (3) New onset AKI resolution at baseline, at 3 days, at 1 week, at 2 weeks, at 4 weeks.

Secondary

MeasureTime frame
Over all mortalityTimepoint: Over all mortality at baseline, at 3 days, at 1 week, at 2 weeks & at 4 weeks.

Countries

India

Contacts

Public ContactDr Bhargav Kiran Gaddam

Mahatma Gandhi Medical College and Research Institute

hanifah4u@yahoo.com9751051602

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026